🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT07502846
Active, not recruiting Not applicable

Superficial vs Deep Serratus Anterior Plane Block for Analgesia After Mammoplasty

NCT07502846 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-11-15
Last updated
2026-03-31

Condition(s) studied

Postoperative Pain ManagementAnalgesia, PostoperativeBreast SurgeryMammoplasty PatientOpioid Consumption

Investigational drug(s) / intervention(s)

Superficial Serratus Anterior Plane BlockDeep Serratus Anterior Plane Block

Superficial Serratus Anterior Plane Block: Ultrasound-guided superficial serratus anterior plane block performed at the mid-axillary line by injecting bupivacaine between the latissimus dorsi and serratus anterior muscles to provide postoperative analgesia in patients undergoing mammoplasty surgery.

Deep Serratus Anterior Plane Block: Ultrasound-guided deep serratus anterior plane block performed at the mid-axillary line by injecting bupivacaine between the serratus anterior muscle and the ribs to provide postoperative analgesia in patients undergoing mammoplasty surgery.

Study summary

The serratus anterior plane block (SAPB) is an ultrasound-guided fascial plane block used for perioperative analgesia in thoracic and breast surgeries. This technique involves the injection of local anesthetic into either the superficial or deep interfascial plane around the serratus anterior muscle at the mid-axillary line, targeting the lateral cutaneous branches of the intercostal nerves and providing analgesia to the anterolateral thoracic wall. The present prospective, comparative, single-blind clinical study aims to compare the postoperative analgesic efficacy of superficial and deep SAPB techniques in patients undergoing mammoplasty surgery. The primary objective is to evaluate total opioid consumption within the first 24 hours postoperatively,while secondary outcomes include postoperative pain scores,additional analgesic requirements, postoperative nausea and vomiting, patient satisfaction, time to first mobilization, and vital signs within the first 24 hours postoperatively. The results of this study may help determine the more effective SAPB technique for improving postoperative pain control and reducing opioid use in patients undergoing mammoplasty.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Female patients aged 18-75 years * ASA physical status I-III * Patients scheduled for elective mammoplasty surgery (unilateral or bilateral) * Patients who voluntarily agree to participate in the study and provide informed consent Exclusion Criteria: * ASA physical status IV or higher * Patients who refuse to participate in the study * Patients who cannot provide informed consent due to language barriers * Pregnant patients * Active infection at the block application site * Previous surgery affecting the anatomical integrity of the block area * Known allergy to local anesthetic agents * Patients with chronic pain or regular analgesic use * Patients with coagulation disorders * Patients with neurological or psychiatric disorders affecting pain perception or those using regular antipsychotic or antidepressant medications * Body mass index (BMI) \> 40 kg/m²

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Başakşehir Çam & Sakura City Hospital Istanbul Basaksehir

More Başakşehir Çam & Sakura City Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07502846 on ClinicalTrials.gov ↗ ← All trials in Turkey